Gisli Jenkins

I won’t be posting here anymore. if you are interested in what I have to share catch up with me @ipfdoc.bsky.social #GoodLuck

[Waggoner Lab @LabWaggoner]

A vaccine strategy to prevent the progression of pulmonary fibrosis @NatImmunol
preview by @IPFdoc, paper from 🇨🇳
https://t.co/ssCsvxvsDl
https://t.co/xRCnITPcSU

[Ali-Reza Mohammadi-Nejad @alirezamnk]

10/
Proud to work alongside brilliant colleagues including: @SNSotiropoulos, @SPMIC_UoN, @IPFdoc, and Dorothee Auer. This work was supported by @NottmBRC and @The_MRC #Demistifi

[Waggoner Lab @LabWaggoner]

People’s brains aged faster during the COVID pandemic — even the uninfected @Nature
https://t.co/zCm5FYmvgf
@NatureComms @alirezamnk @SNSotiropoulos
@SPMIC_UoN @IPFdoc
https://t.co/TCKAcume8n

[Gisli Jenkins @IPFdoc]

@Strava why is your algorithm randomly excluding my segments even when they are not super fast?! Please fix this glitch!

[Gisli Jenkins @IPFdoc]

@atrupar Not like other right wing dictators they said.

[Gisli Jenkins @IPFdoc]

@Acyn Just thinking out loud here but can anybody name all the world leaders in the last 100 years who have invaded (or threaten to invade or otherwise take control of neighbouring states?)

[Gisli Jenkins @IPFdoc]

Post on Bluesky https://t.co/TJtBfYnhKP

[Neuroendocrine Cancer UK #NotJustNECancer @ncukcharity]

Closing date approaching:
£50,000 grants up for grabs - because those with neuroendocrine cancer are less well represented in research with less opportunities to benefit from novel advancements. Please RT: N=@NIHRresearch @BRRichardson1 @aluk_research @IPFdoc @ThoraxBMJ https://t.co/WfWKprEjp2

[REMAP-ILD @REMAP_ILD]

Visit https://t.co/DGOU61z0Sy 💻and stay up-to-date with our latest news. Publications available now to download in Resources section. @IPFdoc @leticiakawano @BerryConsultant #ICLAF2024

[Gisli Jenkins @IPFdoc]

At last the nettle has been grasped. This is an important subject for people with #ILD but is rarely covered and the impacts are huge! Important work from ⁦@KerriBerriKerri⁩ with some actionable advice! #ICLAF2024

[Oliver @Eickelberg_MD]

Fantastic sessions come to a close at day 1 #ICLAF2024 #Athens. Wonderful panel discussion of the history and future of #IPF is followed by closing lecture of the day: The memorial Geoffrey Laurent Lecture given by the one and only @IPFdoc in classic shirt style.

[Juan I Enghelmayer 2022🇦🇷 @Juani1000]

Amazed to wake up this Saturday morning, in the lead-up to #ICLAF2024, and enjoy breakfast with this stunning view of the Acropolis.

[Prof Chris Scotton @Isteefer]

@ActionPFsteve outlining patient priorities. Huge amount of work and optimism, but this slide sums up a frequent patient perspective. So much more to do... #ICLAF2024 #CureIPF

[Gisli Jenkins @IPFdoc]

So pleased to see my good friend ⁦@ActionPFsteve⁩ here at #ICLAF2024. Heard to believe it’s his first! ⁦@ActionPFcharity⁩

[Gisli Jenkins @IPFdoc]

#ICLAF2024 is officially underway! A scientific marathon! I certainly hope so. 🙏🙏 #PatientsKnowBest

[Gisli Jenkins @IPFdoc]

@SimonOKing @darkavenger12a Top of Sawyers Hill in Richmond park. Truly spectacular, the deer 🦌 were enjoying it too! 😊

[Gisli Jenkins @IPFdoc]

@KaminskiMed @KerriBerriKerri @KathleenLindell @atzouvelekis ☺️☺️

[Gisli Jenkins @IPFdoc]

@YuhchinTHuang @KaminskiMed @TobyMMaher @KerriBerriKerri @Boehringer @boehringerus @PFWarrior @PFFORG @ActionPFcharity @pulmonaryfibros @SelmanMoises Roflumilast is pan PDE4 and nerandomilast is a nextgen selective PDE4b inhibitor. Whether this difference is crucial? 🤷🏼‍♂️ However, a lot of preclinical data suggestive roflumilast may have role in IPF thru 📈 cAMP. Not aware of trial to confirm tho. 🤷🏼‍♂️

[Naftali Kaminski @KaminskiMed]

Wow! Boehringer-Ingelheim announces that Nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study - a decade after the first positive phase III trials for IPF. Cannot wait to see the full results but this EXCITING !!!
#CureIPF
https://t.co/TvI1P6uWpc

[Nick Banovich @NeBanovich]

Excited to be launching COSMO. If you are looking to generate spatial transcriptomics data please reach out!